CDC6 and cancer: As illustrated in Figure 6C, in 19 out of 22 (86%) pan‐cancer cohorts, the mRNA level of CDC6 significantly increased in tumor specimens in contrast to those in normal tissues, and this elevated CDC6 expression was associated with unfavorable OS (Figure S7, Supporting Information).